In-Person Access Only | 7.50 CME Credits & MOC Points
Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com
Total Health's 2026 Best of ASCO® Seattle Conference is an officially licensed Best of ASCO® meeting. This Post ASCO® Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference only with on-demand access for registered attendees.
Program Chairs:
Petros Grivas, MD, PhD (University of Washington)
Jennifer Specht, MD (Fred Hutch Cancer Center)
Conference Agenda
Saturday, July 25, 2026
8:00 AM
Coffee and Exhibits
8:30 AM
Program Chair Welcome
Petros Grivas, MD, PhD | University of Washington
8:40 AM
Colorectal Cancer
Ronan Hsieh, MD | Swedish Cancer Institute
9:10 AM
Non-Colorectal Cancer
David Zhen, MD | Fred Hutch Cancer Center
9:40 AM
Breakfast and Exhibits
9:55 AM
Non-CME Breakfast - Exelixis A Combination Treatment for Patients with Advanced Renal Cell Carcinoma
Munveer Bhangoo, MD | Scripps Cancer Center
10:40 AM
Prostate Cancer
Joseph Kim, MD | Yale University
11:10 AM
Non-Prostate Cancer
Petros Grivas, MD, PhD | University of Washington
11:40 AM
Lunch and Exhibits
11:55 AM
Non-CME Lunch - Incyte Make a Change in cGVHD Treatment Strategy and Provide Rapid, Durable Responses
Amandeep Salhotra, MD | City of Hope
12:40 PM
Housekeeping and Survey
12:50 PM
Leukemia
Tapan Kadia, MD | MD Anderson Cancer Center
1:20 PM
Lymphoma
Patrick Johnson, MD | Mass General Brigham
1:50 PM
Multiple Myeloma
Jeffrey Matous, MD | Colorado Blood Cancer Institute
2:20 PM
Melanoma
Mohamed Gouda, MD | MD Anderson Cancer Center
2:50 PM
Adjourn
Sunday, July 26, 2026
7:30 AM
Coffee and Exhibits
8:00 AM
Program Chair Welcome
Jennifer Specht, MD | Fred Hutch Cancer Center
8:10 AM
Small Cell Lung Cancer
Jyoti Malhotra, MD | City of Hope California
8:40 AM
Non-Small Cell Lung Cancer
Shiven Patel, MD | Huntsman Cancer Institute
9:10 AM
The Emerging Role of PD-1 × VEGF Bispecific Antibodies in NSCLC
Jyoti Malhotra, MD | City of Hope California
9:30 AM
Breakfast and Exhibits
9:55 AM
Non-CME Breakfast - (Sumitomo/Pfizer Orgovyx) - Orgovyx(r) (relugolix): The Only Oral ADT for Advanced Prostate Cancer
Chandler H Park, MD | Norton Healthcare
10:40 AM
Head and Neck Cancer
Ezra Cohen, MD | University of California San Diego
11:10 AM
Sarcomas and Rare Cancers
Lara Davis, MD | Fred Hutch Cancer Center
11:40 AM
Lunch and Exhibits
11:55 AM
Non-CME Lunch - Natera - Shaping the Future of Precision Medicine with MRD
Soma Subramaniam, MD | Natera
12:40 PM
Survivorship
Timo Lara, RN, MSN, NP-C, AOCNP | Saint John's Health Center
1:10 PM
Metastatic Breast Cancer
Jennifer Specht, MD | Fred Hutch Cancer Center
1:40 PM
Early-Stage Breast Cancer
Fengting Yan, MD | Fred Hutch Cancer Center
2:10 PM
Adjourn
Agenda Subject To Change. All times are PDT.
-
Integrate new evidence into everyday clinical practice, thereby improving the quality of care being delivered to patients living with and beyond cancer.
Implement practice changes in a variety of treatment options for solid tumors, including lung, breast, melanoma, colorectal, non-colorectal GI, and GU cancers
Stimulate innovative strategies for new and additional research related to treatment and prevention
Recognize the implications for practice change in both the academic and community practice settings
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 7.50 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 7.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 7.50 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Enduring video content for watching at your leisure
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program